OT Meriden enhances its product portfolio

[Guest guest]

Meriden enhances its product portfolio PUBLICATION DATE: 03/08/2010

COMPANY: Meriden Animal Health Limited

SOURCE: Meriden

The launch of Fusion® - the next generation of toxin binder

http://en.engormix.com/MA-mycotoxins/news/meriden-enhances-its-product_15891.htm

Fusion® is the next generation of toxin binder that also has great antifungal,

ammonia binding properties and is an anti-caking agent. This unique product, in

addition to its toxin binding advantages, offers analogous properties of a great

source of essential amino acids, vitamins and other nutrients required to

improve animal health and to boost performance.

The individual components contained in Fusion® have specific characteristics and

modes of actions that work synergistically to benefit all animal species.

F - Fixes Mycotoxins

U - Utilises the Feed

S - Synergistic Effect

I - Immune Booster

O - Orego-Stim added

N - Nutritional Benefits

Mycotoxicosis is a well-known immunosuppressant caused by mycotoxins in animal

feeds, increasing the risk of scouring, acidosis, enteritis and other

gastrointestinal tract problems. The best solution to prevent mycotoxicosis in

animals, in order to prevent the risk of zoonosis and reduce the detrimental

effects caused by mycotoxins, is to include a high quality mycotoxin binder in

animal feeds. Meriden Animal Health Limited has specifically created the high

affinity mycotoxin binder, Fusion®, which safely binds various mycotoxin

derivatives within the animal's gastrointestinal tract, as well as inhibiting

mould and fungus growth in feed.

With its high binding capacity against mycotoxins such as, Deoxynivalenol,

Fumonisin B1, Zearalenone, Vomitoxin, Aflatoxines (B1, B2, G1, G2), Ochratoxine

A and T-2, Fusion® protects and strengthens the immune system. Thus, the

animal's immune system is able to function normally and defend against various

respiratory and gastrointestinal diseases. This enables proper growth and

development of bone tissue and structure and minimises the risk of secondary

bacterial invaders such as E. coli and Salmonella spp.

As well as fixing mycotoxins Fusion® increases growth rate and daily weight gain

by improving FCR. Meanwhile, it reduces scouring, acidosis, enteritis and other

gastrointestinal tract problems.

Fungal moulds in food and feed ingredients are the pre-cursor to mycotoxins.

University studies have shown that Fusion® has great antifungal properties that

can kill Aspergillus and Penicillium strains that produce a wide range of

mycotoxins that can cause great economical losses in animal industry. Fusion®

can kill the fungal precursors preventing or reducing the mycotoxin presence,

which in turn reduces the economic loss and increases returns.

Fusion® is suitable for all types of animal feeds.

PUBLICATION DATE: 03/08/2010

COMPANY: Meriden Animal Health Limited

SOURCE: Meriden

[Guest guest]

Leave it to the veterinary field. They're always miles ahead of human

medicine.

Barth

www.presenting.net/sbs/sbs.html

SUBMIT YOUR DOCTOR: www.presenting.net/sbs/molddoctors.html

---

K> Meriden enhances its product portfolio PUBLICATION DATE: 03/08/2010

K> COMPANY: Meriden Animal Health Limited

K> SOURCE: Meriden

K> The launch of Fusion® - the next generation of toxin binder

K>

http://en.engormix.com/MA-mycotoxins/news/meriden-enhances-its-product_15891.htm